JP2020533270A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020533270A5 JP2020533270A5 JP2019560097A JP2019560097A JP2020533270A5 JP 2020533270 A5 JP2020533270 A5 JP 2020533270A5 JP 2019560097 A JP2019560097 A JP 2019560097A JP 2019560097 A JP2019560097 A JP 2019560097A JP 2020533270 A5 JP2020533270 A5 JP 2020533270A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- receptor agonist
- serotonin receptor
- retinal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762492841P | 2017-05-01 | 2017-05-01 | |
| US62/492,841 | 2017-05-01 | ||
| PCT/US2018/030448 WO2018204359A1 (en) | 2017-05-01 | 2018-05-01 | Compositions and methods for treating ocular pathologies |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2020533270A JP2020533270A (ja) | 2020-11-19 |
| JP2020533270A5 true JP2020533270A5 (https=) | 2021-05-27 |
Family
ID=64017034
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019560097A Pending JP2020533270A (ja) | 2017-05-01 | 2018-05-01 | 眼の病態を治療するための組成物および方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US11759438B2 (https=) |
| EP (1) | EP3618850A4 (https=) |
| JP (1) | JP2020533270A (https=) |
| KR (2) | KR20230135163A (https=) |
| CN (1) | CN110662549A (https=) |
| AU (2) | AU2018263853A1 (https=) |
| CA (1) | CA3061900A1 (https=) |
| WO (1) | WO2018204359A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4219498A1 (en) * | 2019-03-07 | 2023-08-02 | Arbormentis LLC | Compositions and methods of use comprising substances with neural plasticity actions administered at non-psychedelic / psychotomimetic dosages and formulations |
| US11312684B1 (en) | 2021-02-10 | 2022-04-26 | Eleusis Therapeutics Us, Inc. | Pharmaceutically acceptable salts of psilocin and uses thereof |
| JPWO2023048174A1 (https=) * | 2021-09-22 | 2023-03-30 | ||
| WO2024010765A1 (en) * | 2022-07-05 | 2024-01-11 | Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College | Compositions for treating 5-ht2 conditions and methods of using the same |
| AU2023317872A1 (en) | 2022-08-04 | 2025-03-13 | Synex Holdings Bv | Prodrugs of substituted ergolines |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5554617A (en) * | 1979-09-28 | 1996-09-10 | The Upjohn Company | Method for treating cancer with 6-aryl pyrimidine compounds |
| US5545617A (en) | 1993-11-12 | 1996-08-13 | The Schepens Eye Research Institute, Inc. | Therapeutic regulation of abnormal conjunctival goblet cell mucous secretion |
| WO1996014060A1 (en) * | 1994-11-04 | 1996-05-17 | Marklund Stefan L | Use of receptor agonists to stimulate superoxide dismutase activity |
| US20090191288A1 (en) * | 1996-02-12 | 2009-07-30 | Squires Meryl J | Composition to Treat Herpes, Pseudomonas, Staph, Hepatitis and Other Infectious Diseases |
| DE69710258T2 (de) * | 1996-06-17 | 2002-08-22 | Mitsubishi Chemical Corp., Tokio/Tokyo | Mittel zur Beschleunigung des Tränenflusses enthaltend einen Serotonin-Liganden, insbesondere Aminoalkoxybibenzyle |
| JPH1067684A (ja) * | 1996-06-17 | 1998-03-10 | Mitsubishi Chem Corp | 涙液分泌促進剤 |
| US20030207890A1 (en) * | 2001-02-23 | 2003-11-06 | Collier Robert J | Compounds with 5-ht1a activity useful for treating disorders of the outer retina |
| US20040058313A1 (en) * | 2002-04-24 | 2004-03-25 | Abreu Marcio Marc | Compositions, targets, methods and devices for the therapy of ocular and periocular disorders |
| WO2006029182A2 (en) * | 2004-09-07 | 2006-03-16 | The La Jolla Institute For Molecular Medicine | Use of mdl-100,907 for treatment of allergic and eosinophil mediated diseases |
| TNSN08110A1 (en) * | 2008-03-11 | 2009-07-14 | Rekik Raouf Dr | Drug delivery to the anterior and posterior segment of the eye from drops |
| US8859579B2 (en) * | 2008-03-21 | 2014-10-14 | Richard Andrew Sewell | Compostions and methods for preventing and/or treating disorders associated with cephalic pain |
| US9642819B2 (en) * | 2008-07-10 | 2017-05-09 | Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical | Low dosage serotonin 5-HT2A receptor agonist to suppress inflammation |
| US9271980B2 (en) * | 2009-08-03 | 2016-03-01 | Daljit Singh Dhanoa | Deuterium-enriched pyrimidine compounds and derivatives |
| TWI719277B (zh) * | 2011-11-14 | 2021-02-21 | 美商安斯泰來再生醫藥協會 | 人類rpe細胞之醫藥組合物及其用途 |
| US8877183B2 (en) * | 2012-06-26 | 2014-11-04 | National Institutes Of Health (Nih) | Methods for treatment of ocular diseases |
| US11033554B2 (en) | 2015-07-24 | 2021-06-15 | United States Government As Represented By The Department Of Veterans Affairs | Use of dopamine and serotonin receptor antagonists for treatment in a subject with retinal degeneration |
-
2018
- 2018-05-01 CA CA3061900A patent/CA3061900A1/en active Pending
- 2018-05-01 AU AU2018263853A patent/AU2018263853A1/en not_active Abandoned
- 2018-05-01 JP JP2019560097A patent/JP2020533270A/ja active Pending
- 2018-05-01 WO PCT/US2018/030448 patent/WO2018204359A1/en not_active Ceased
- 2018-05-01 US US16/610,382 patent/US11759438B2/en active Active
- 2018-05-01 CN CN201880034321.XA patent/CN110662549A/zh active Pending
- 2018-05-01 KR KR1020237030827A patent/KR20230135163A/ko not_active Ceased
- 2018-05-01 KR KR1020197035398A patent/KR20200003110A/ko not_active Ceased
- 2018-05-01 EP EP18794658.7A patent/EP3618850A4/en not_active Withdrawn
-
2024
- 2024-02-12 AU AU2024200866A patent/AU2024200866A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020533270A5 (https=) | ||
| JP6494528B2 (ja) | フッ化インテグリンアンタゴニスト | |
| JP2021515777A (ja) | 眼科用製剤 | |
| US12370209B2 (en) | Methods for the use of 5′-adenosine diphosphate ribose (ADPR) | |
| CN107708738B (zh) | 含有柠檬酸酯的贮库制剂 | |
| JP2014533275A5 (https=) | ||
| CN101678006A (zh) | 含有非麦角类的选择性d2受体激动剂作为有效成分的后眼部疾病的预防或治疗剂 | |
| JP2011530496A (ja) | 眼新生血管形成症状の治療のためのソラフェニブを含む眼科用医薬組成物 | |
| JP2025106418A (ja) | エンドセリンレセプターアンタゴニストを使用する眼疾患の処置 | |
| JP2021503449A5 (https=) | ||
| JP2013500977A5 (https=) | ||
| CN115103842A (zh) | 用于治疗眼部疾病的组合物 | |
| ME02608B (me) | Kombinacija, komplet i postupak snižavanja intraokularnog pritiska | |
| CN110662549A (zh) | 用于治疗眼病的组合物和方法 | |
| US10537563B2 (en) | Methods for treating ocular disease using inhibitors of CSF-1R | |
| JP2019534269A5 (https=) | ||
| JP2021138710A5 (https=) | ||
| JP2005047909A (ja) | ピペリジン誘導体を有効成分とする掻痒治療剤 | |
| JP2020530459A5 (https=) | ||
| CA3014071C (en) | Methods for the use of 5'-adenosine diphosphate ribose (adpr) | |
| JP2009517375A (ja) | 眼の疾患の治療 | |
| JP2020114847A5 (https=) | ||
| HK40073052A (en) | Medical use of 5'-adenosine diphosphate ribose (adpr) | |
| AU2023221950A1 (en) | Treatment of anatomical and functional retinal atrophies | |
| TW201639589A (zh) | 含有多肽之醫藥組成物 |